P/E ratio for Accelerate Diagnostics (AXDX)
P/E ratio as of April 2024 (TTM): -0.0978
According to Accelerate Diagnostics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.0978399. At the end of 2022 the company had a P/E ratio of -0.0931.
P/E ratio history for Accelerate Diagnostics from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -0.0931 | -77.36% |
| 2021 | -0.4110 | -24.09% |
| 2020 | -0.5414 | -50.66% |
| 2019 | -1.10 | 54.59% |
| 2018 | -0.7099 | -68.03% |
| 2017 | -2.22 | 38.04% |
| 2016 | -1.61 | -24.4% |
| 2015 | -2.13 | -21.28% |
| 2014 | -2.70 | -6.95% |
| 2013 | -2.90 | 231.56% |
| 2012 | -0.8761 | -42.08% |
| 2011 | -1.51 | -269.58% |
| 2010 | 0.8919 | -195.56% |
| 2009 | -0.9333 | -43.19% |
| 2008 | -1.64 | -32.58% |
| 2007 | -2.44 | 228.97% |
| 2006 | -0.7407 | -41.52% |
| 2005 | -1.27 | -39.68% |
| 2004 | -2.10 | 52.73% |
| 2003 | -1.38 | -62.07% |
| 2002 | -3.63 | 274.41% |
| 2001 | -0.9682 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 35.3 | -36,180.58% | 🇺🇸 USA |
 Becton Dickinson BDX | 42.0 | -43,036.47% | 🇺🇸 USA |
 PerkinElmer
PKI | 15.0 | -15,397.03% | 🇺🇸 USA |
 Bruker BRKR | 36.2 | -37,102.08% | 🇺🇸 USA |
 NanoString Technologies NSTG | -0.0297 | -69.60% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -49.1 | 50,114.07% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.